Page last updated: 2024-10-27

fluoxetine and Decerebrate Posturing

fluoxetine has been researched along with Decerebrate Posturing in 2 studies

Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Neal, H1
Bond, A1
Bymaster, FB1
Perry, KW1
Fuller, RW1
Wong, DT1

Other Studies

2 other studies available for fluoxetine and Decerebrate Posturing

ArticleYear
Modification of PGO activity by specific uptake inhibitors fluoxetine, nisoxetine and LR5182.
    Neuropharmacology, 1979, Volume: 18, Issue:10

    Topics: 2H-Benzo(a)quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-; Animals; Bri

1979
Nisoxetine prevents the 6-hydroxydopamine induced decrease in post-decapitation convulsions.
    Life sciences, 1977, Jan-15, Volume: 20, Issue:2

    Topics: Animals; Brain Stem; Cerebral Cortex; Decerebrate State; Desipramine; Dose-Response Relationship, Dr

1977